The FACT-G7: A rapid version of the functional assessment of cancer therapy-general (FACT-G) for monitoring symptoms and concerns in oncology practice and research

Annals of Oncology

Volumn 24, Issue 4, 2013, Pages 1073-1078

  Yanez, B ^a   Pearman, T ^a   Lis, C G ^b   Beaumont, J L ^a   Cella, D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CANCER TREATMENT CENTERS OF AMERICA   (United States)

Author keywords

Cancer; Health related quality of life; Patient centered outcomes; Symptom index

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; BILE DUCT CANCER; BLADDER CANCER; BRAIN CANCER; BREAST CANCER; CANCER PATIENT; CANCER STAGING; CANCER THERAPY; CLINICAL PRACTICE; CLINICAL RESEARCH; COLORECTAL CANCER; COMORBIDITY; CONTROLLED STUDY; FATIGUE; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL ASSESSMENT OF CANCER THERAPY GENERAL; HEAD AND NECK CANCER; HUMAN; INTERNAL CONSISTENCY; KIDNEY CANCER; LIVER CANCER; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; ONCOLOGY; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; RELIABILITY;

EID: 84875588434     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds539     Document Type: Article

References (24)

1. Aaronson NK, Ahmedzai S, Bergman B et al.. The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-376.
2. Yanez B, Edmondson D, Stanton AL. Facets of spirituality as predictors of adjustment to cancer: relative contributions of having faith and finding meaning. J Consult Clin Psychol 2009; 77: 730-741.
3. Velikova G, Awad N, Coles-Gale R et al.. The clinical value of quality of life assessment in oncology practice-a qualitative study of patient and physician views. Psychooncology 2008; 17: 690-698.
4. Seyidova-Khoshknabi D, Davis MP, Walsh D. Review article: a systematic review of cancer related fatigue management questionnaires. Am J Palliat Care 2011; 28: 119-129.
5. Webber K, Davies AN. Validity of the memorial symptom assessment scale-short form psychological subscales in advanced cancer patients. J Pain Symptom Manage 2011; 42: 761-767.
6. Bateman E, Keefe D. Patient-reported outcomes in supportive care. Semin Oncol 2011; 38: 358-361.
7. Lo C, Burman D, Swami N et al.. Validation of QUAL-EC for assessing quality of life in patients with advanced cancer. Eur J Cancer 2011; 47: 554-560.
8. Gotay CC, Kawamoto CT, Bottomley A et al. The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol 2008; 26: 1355-1363.
9. Cleeland CS. Symptom burden: Multiple symptoms and their impact as patientreported outcomes. J Natl Cancer Inst Monogr 2007; 37: 16-21.
10. Gabrilove JL, Perez EA, Tomita DK et al.. Assessing symptom burden using the MD Anderson symptom inventory in patients with chemotherapy induced anemia: results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200 microg every two weeks. Cancer 2007; 110: 1629-1640.
11. Ruland CM, Holte HH, Roislien J et al.. Effects of a computer-supported interactive tailored patient assessment tool on patient care, symptom distress, and patients' need for symptom management support: a randomized clinical trial. J Am Med Inform Assoc 2010; 17: 403-410.
12. Clark PG, Rochon E, Brethwaite D et al.. Screening for psychological and physical distress in a cancer inpatient treatment setting: a pilot study. Psychooncology 2011; 20: 664-668.
13. Manitta V, Zordan R, Cole-Sinclair M et al.. The symptom burden of patients with hematologic malignancies: a cross-sectional observational study. J Pain Symptom Manage 2011; 42: 432-442.
14. Cella DF, Tulsky DS, Gray G et al.. The Functional Assessment of Cancer Therapy (FACT) Scale: development and validation of the general measure. J Clin Oncol 1993; 11: 570-579.
15. Cella D, Rosenbloom SK, Beaumont JL et al.. Development and validation of 11 symptom indexes to evaluate response to chemotherapy for advanced cancer. J Natl Compr Cancer Netw 2011; 9: 268-278.
16. Deyo RA, Patrick D. Barriers to the use of health status measures in clinical investigation, patient care, and policy research. Med Care 1989; 27: s254-S267.
17. Petersen MA, Groenvold M, Aaronson N et al.. Item response theory was used to shorten the EORTC QLQ-C30 scales for use in palliative care. J Clin Epidemiol 2006; 59: 36-44.
18. Butt Z, Peipert D, Webster K et al.. General population norms for the functional assessment of cancer therapy-kidney symptom index (FKSI). Cancer 2012 July 6 [Epub ahead of print] DOI:10.1002/cncr.27688.
19. Cella D, Riley W, Stone A et al.. The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult selfreported health outcome item banks: 2005-2008. J Clin Epidemiol 2010; 63: 1179-1194.
20. Oken M, Creech RTD, Horton J et al.. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649-655.
21. Eton DT, Cella D, Yost KJ et al.. A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale. J Clin Epidemiol 2004; 57: 898-910.
22. Sternberg CN, Davis ID, Mardiak J et al.. Pazopanib in locally advanced and/or metastatic renal cell carcinoma: results of a randomized phase III trial. J Clin Oncol 2010; 28: 1061-1068.
23. Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Meth 2006; 18: 59-82.
24. Nunnally JC, Bernstein IR. Psychometric theory. 3rd edition. New York, McGraw-Hill 1994.